Hepatic resection beyond barcelona clinic liver cancer indication: When and how

World Journal of Hepatology

Volumn 8, Issue 11, 2016, Pages 513-519

  Garancini, Mattia ^a   Pinotti, Enrico ^a   Nespoli, Stefano ^a   Romano, Fabrizio ^a   Gianotti, Luca ^a   Giardini, Vittorio ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

Barcelona clinic liver cancer; Cirrhosis; Hepatic resection; Hepatocellular carcinoma; Intraoperative ultrasound; Laparoscopy; Liver surgery; Multidisciplinary approach; Multiple hepatocellular carcinoma; Portal hypertension

Indexed keywords

EID: 84963563062     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v8.i11.513     Document Type: Review

References (54)

1. Lafaro KJ, Demirjian AN, Pawlik TM. Epidemiology of hepatocellular carcinoma. Surg Oncol Clin N Am 2015; 24: 1-17 [PMID: 25444466 DOI: 10.1016/j.soc.2014.09.001]
2. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J; EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430 [PMID: 11592607 DOI: 10.1016/S0168-8278(01)00130-1]
3. Singal AG, El-Serag HB. Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. Clin Gastroenterol Hepatol 2015; 13: 2140-2151 [PMID: 26284591 DOI: 10.1016/j.cgh.2015.08.014]
4. Torzilli G, Donadon M, Marconi M, Palmisano A, Del Fabbro D, Spinelli A, Botea F, Montorsi M. Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis. Arch Surg 2008; 143: 1082-1090 [PMID: 19015467 DOI: 10.1001/archsurg.143.11.1082]
5. Choi C, Choi GH, Kim TH, Tanaka M, Meng MB, Seong J. Multimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma. Liver Cancer 2014; 3: 405-416 [PMID: 26280002 DOI: 10.1159/000343861]
6. Schlachterman A, Craft WW, Hilgenfeldt E, Mitra A, Cabrera R. Current and future treatments for hepatocellular carcinoma. World J Gastroenterol 2015; 21: 8478-8491 [PMID: 26229392 DOI: 10.3748/wjg.v21.i28.8478]
7. Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Vitali M, Bertuzzo F, De Angelis M, Mantovani G, Iacono C. Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations. World J Gastroenterol 2014; 20: 7525-7533 [PMID: 24976693 DOI: 10.3748/wjg.v20.i24.7525]
8. Ho MC, Huang GT, Tsang YM, Lee PH, Chen DS, Sheu JC, Chen CH. Liver resection improves the survival of patients with multiple hepatocellular carcinomas. Ann Surg Oncol 2009; 16: 848-855 [PMID: 19159983 DOI: 10.1245/s10434-008-0282-7]
9. Forner A, Gilabert M, Bruix J, Raoul JL. Treatment of intermediate-stage hepatocellular carcinoma. Nat Rev Clin Oncol 2014; 11: 525-535 [PMID: 25091611 DOI: 10.1038/nrclinonc.2014.122]
10. Zhou Y, Lei X, Wu L, Wu X, Xu D, Li B. Outcomes of hepatectomy for noncirrhotic hepatocellular carcinoma: a systematic review. Surg Oncol 2014; 23: 236-242 [PMID: 25465529 DOI: 10.1016/j.suronc.2014.11.001]
11. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 2002; 236: 602-611 [PMID: 12409666 DOI: 10.1097/01.SLA.0000033038.38956.5E]
12. Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo PC. Predictive indices of morbidity and mortality after liver resection. Ann Surg 2006; 243: 373-379 [PMID: 16495703 DOI: 10.1097/01.sla.0000201483.95911.08]
13. Zhang ZM, Guo JX, Zhang ZC, Jiang N, Zhang ZY, Pan LJ. Therapeutic options for intermediate-advanced hepatocellular carcinoma. World J Gastroenterol 2011; 17: 1685-1689 [PMID: 21483627 DOI: 10.3748/wjg.v17.i13.1685]
14. Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E, Donadon M, Morenghi E, Makuuchi M. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg 2013; 257: 929-937 [PMID: 23426336 DOI: 10.1097/SLA.0b013e31828329b8]
15. Zhong JH, Xiang BD, Gong WF, Ke Y, Mo QG, Ma L, Liu X, Li LQ. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization. PLoS One 2013; 8: e68193 [PMID: 23874536 DOI: 10.1371/journal.pone.0068193]
16. Tsoulfas G, Mekras A, Agorastou P, Kiskinis D. Surgical treatment for large hepatocellular carcinoma: does size matter? ANZ J Surg 2012; 82: 510-517 [PMID: 22548726 DOI: 10.1111/j.1445-2197.2012.06079]
17. Ruzzenente A, Guglielmi A, Sandri M, Campagnaro T, Valdegamberi A, Conci S, Bagante F, Turcato G, D'Onofrio M, Iacono C. Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study. J Gastrointest Surg 2012; 16: 301-311; discussion 311 [PMID: 22095524 DOI: 10.1007/s11605-011-1745-x]
18. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Brú C, Rodés J, Bruix J. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29: 62-67 [PMID: 9862851 DOI: 10.1002/hep.510290145]
19. Zhong JH, Ke Y, Gong WF, Xiang BD, Ma L, Ye XP, Peng T, Xie GS, Li LQ. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg 2014; 260: 329-340 [PMID: 24096763 DOI: 10.1097/SLA.0000000000000236]
20. Zhong JH, Li H, Xiao N, Ye XP, Ke Y, Wang YY, Ma L, Chen J, You XM, Zhang ZY, Lu SD, Li LQ. Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension. PLoS One 2014; 9: e108755 [PMID: 25268959 DOI: 10.1371/journal.pone.0108755]
21. Santambrogio R, Kluger MD, Costa M, Belli A, Barabino M, Laurent A, Opocher E, Azoulay D, Cherqui D. Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication? HPB (Oxford) 2013; 15: 78-84 [PMID: 23216782 DOI: 10.1111/j.1477-2574.2012.00594.x]
22. He W, Zeng Q, Zheng Y, Chen M, Shen J, Qiu J, Chen M, Zou R, Liao Y, Li Q, Wu X, Li B, Yuan Y. The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis. BMC Cancer 2015; 15: 263 [PMID: 25886495 DOI: 10.1186/s12885-015-1280-3]
23. Hirokawa F, Hayashi M, Miyamoto Y, Asakuma M, Shimizu T, Komeda K, Inoue Y, Uchiyama K. Predictors of poor prognosis by recurrence patterns after curative hepatectomy for hepatocellular carcinoma in Child-Pugh classification A. Hepatogastroenterology 2015; 62: 164-168 [PMID: 25911889]
24. Wang Y, Yuan L, Ge RL, Sun Y, Wei G. Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: results of a retrospective cohort study. Ann Surg Oncol 2013; 20: 914-922 [PMID: 22956071 DOI: 10.1245/s10434-012-2646-2]
25. Chok KS, Cheung TT, Chan SC, Poon RT, Fan ST, Lo CM. Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis. World J Surg 2014; 38: 490-496 [PMID: 24132826 DOI: 10.1007/s00268-013-2290-4]
26. Kanazawa A, Tsukamoto T, Shimizu S, Kodai S, Yamazoe S, Yamamoto S, Kubo S. Impact of laparoscopic liver resection for hepatocellular carcinoma with F4-liver cirrhosis. Surg Endosc 2013; 27: 2592-2597 [PMID: 23392977]
27. Violi F, Leo R, Vezza E, Basili S, Cordova C, Balsano F. Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalities. C.A.L.C. Group. Coagulation Abnormalities in Cirrhosis Study Group. J Hepatol 1994; 20: 531-536 [PMID: 8051393]
28. Lencioni R, Chen XP, Dagher L, Venook AP. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? Oncologist 2010; 15 Suppl 4: 42-52 [PMID: 21115580 DOI: 10.1634/theoncologist.2010-S4-42]
29. Gish RG, Lencioni R, Di Bisceglie AM, Raoul JL, Mazzaferro V. Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 2012; 6: 173-185 [PMID: 22375523 DOI: 10.1586/egh.11.105]
30. Gomaa AI, Waked I. Recent advances in multidisciplinary management of hepatocellular carcinoma. World J Hepatol 2015; 7: 673-687 [PMID: 25866604 DOI: 10.4254/wjh.v7.i4.673]
31. Gaba RC, Kallwitz ER, Parvinian A, Bui JT, Von Roenn NM, Berkes JL, Cotler SJ. Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients. Ann Hepatol 2013; 12: 766-773 [PMID: 24018494]
32. Torzilli G, Palmisano A, Del Fabbro D, Marconi M, Donadon M, Spinelli A, Bianchi PP, Montorsi M. Contrast-enhanced intraoperative ultrasonography during surgery for hepatocellular carcinoma in liver cirrhosis: is it useful or useless? A prospective cohort study of our experience. Ann Surg Oncol 2007; 14: 1347-1355 [PMID: 17253105 DOI: 10.1245/s10434-006-9278-3]
33. Wu H, Lu Q, Luo Y, He XL, Zeng Y. Application of contrast-enhanced intraoperative ultrasonography in the decision-making about hepatocellular carcinoma operation. World J Gastroenterol 2010; 16: 508-512 [PMID: 20101780 DOI: 10.3748/wjg.v16. i4.508]
34. Torzilli G, Montorsi M, Donadon M, Palmisano A, Del Fabbro D, Gambetti A, Olivari N, Makuuchi M. "Radical but conservative" is the main goal for ultrasonography-guided liver resection: prospective validation of this approach. J Am Coll Surg 2005; 201: 517-528 [PMID: 16183489 DOI: 10.1016/j.jamcollsurg.2005.04.026]
35. Torzilli G, Palmisano A, Procopio F, Cimino M, Botea F, Donadon M, Del Fabbro D, Montorsi M. A new systematic small for size resection for liver tumors invading the middle hepatic vein at its caval confluence: mini-mesohepatectomy. Ann Surg 2010; 251: 33-39 [PMID: 19858707 DOI: 10.1097/SLA.0b013e3181b61db9]
36. Torzilli G, Garancini M, Donadon M, Cimino M, Procopio F, Montorsi M. Intraoperative ultrasonographic detection of communicating veins between adjacent hepatic veins during hepatectomy for tumours at the hepatocaval confluence. Br J Surg 2010; 97: 1867-1873 [PMID: 20799289 DOI: 10.1002/bjs.7230]
37. Slotta JE, Kollmar O, Ellenrieder V, Ghadimi BM, Homayounfar K. Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives. World J Hepatol 2015; 7: 1168-1183 [PMID: 26019733 DOI: 10.4254/wjh.v7.i9.1168]
38. Zhou Y, Xu D, Wu L, Li B. Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Langenbecks Arch Surg 2011; 396: 1109-1117 [PMID: 21476060 DOI: 10.1007/s00423-011-0784-9]
39. Makuuchi M, Hasegawa H, Yamazaki S. Intraoperative ultrasonic examination for hepatectomy. Ultrasound Med Biol 1983; Suppl 2: 493-497 [PMID: 6100712]
40. Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985; 161: 346-350 [PMID: 2996162]
41. Shimamura Y, Gunvén P, Takenaka Y, Shimizu H, Akimoto H, Shima Y, Arima K, Takahashi A, Kitaya T, Matsuyama T. Selective portal branch occlusion by balloon catheter during liver resection. Surgery 1986; 100: 938-941 [PMID: 3022413]
42. Park YS, Lee CH, Park PJ, Kim KA, Park CM. Intraoperative contrast-enhanced sonographic portography combined with indigo carmine dye injection for anatomic liver resection in hepatocellular carcinoma: a new technique. J Ultrasound Med 2014; 33: 1287-1291 [PMID: 24958416 DOI: 10.7863/ultra.33.7.1287]
43. Torzilli G, Procopio F, Cimino M, Del Fabbro D, Palmisano A, Donadon M, Montorsi M. Anatomical segmental and subsegmental resection of the liver for hepatocellular carcinoma: a new approach by means of ultrasound-guided vessel compression. Ann Surg 2010; 251: 229-235 [PMID: 19838106 DOI: 10.1097/SLA.0b013e3181b7fdcd]
44. Chen J, Huang K, Wu J, Zhu H, Shi Y, Wang Y, Zhao G. Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci 2011; 56: 1626-1633 [PMID: 21082347 DOI: 10.1007/s10620-010-1482-0]
45. Mirnezami R, Mirnezami AH, Chandrakumaran K, Abu Hilal M, Pearce NW, Primrose JN, Sutcliffe RP. Short- and long-term outcomes after laparoscopic and open hepatic resection: systematic review and meta-analysis. HPB (Oxford) 2011; 13: 295-308 [PMID: 21492329 DOI: 10.1111/j.1477-2574.2011.00295.x]
46. Nguyen KT, Gamblin TC, Geller DA. World review of laparoscopic liver resection-2,804 patients. Ann Surg 2009; 250: 831-841 [PMID: 19801936 DOI: 10.1097/SLA.0b013e3181b0c4df]
47. Buell JF, Cherqui D, Geller DA, O'Rourke N, Iannitti D, Dagher I, Koffron AJ, Thomas M, Gayet B, Han HS, Wakabayashi G, Belli G, Kaneko H, Ker CG, Scatton O, Laurent A, Abdalla EK, Chaudhury P, Dutson E, Gamblin C, D'Angelica M, Nagorney D, Testa G, Labow D, Manas D, Poon RT, Nelson H, Martin R, Clary B, Pinson WC, Martinie J, Vauthey JN, Goldstein R, Roayaie S, Barlet D, Espat J, Abecassis M, Rees M, Fong Y, McMasters KM, Broelsch C, Busuttil R, Belghiti J, Strasberg S, Chari RS. The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg 2009; 250: 825-830 [PMID: 19916210]
48. Santambrogio R, Aldrighetti L, Barabino M, Pulitanò C, Costa M, Montorsi M, Ferla G, Opocher E. Laparoscopic liver resections for hepatocellular carcinoma. Is it a feasible option for patients with liver cirrhosis? Langenbecks Arch Surg 2009; 394: 255-264 [PMID: 18553101 DOI: 10.1007/s00423-008-0349-8]
49. Xiong JJ, Altaf K, Javed MA, Huang W, Mukherjee R, Mai G, Sutton R, Liu XB, Hu WM. Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma. World J Gastroenterol 2012; 18: 6657-6668 [PMID: 23236242 DOI: 10.3748/wjg.v18. i45.6657]
50. Slim A, Garancini M, Di Sandro S, Mangoni I, Lauterio A, Giacomoni A, De Carlis L. Laparoscopic versus open liver surgery: a single center analysis of post-operative in-hospital and postdischarge results. Langenbecks Arch Surg 2012; 397: 1305-1311 [PMID: 22918605 DOI: 10.1007/s00423-012-0992-y]
51. Santambrogio R, Barabino M, Bruno S, Costa M, Ceretti AP, Angiolini MR, Zuin M, Meloni F, Opocher E. Long-term outcome of laparoscopic ablation therapies for unresectable hepatocellular carcinoma: a single European center experience of 426 patients. Surg Endosc 2015; Epub ahead of print [PMID: 26275555 DOI: 10.1007/s00464-015-4468-3]
52. Santambrogio R, Opocher E, Zuin M, Selmi C, Bertolini E, Costa M, Conti M, Montorsi M. Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis. Ann Surg Oncol 2009; 16: 3289-3298 [PMID: 19727960 DOI: 10.1245/s10434-009-0678-z]
53. Lai EC, Tang CN, Ha JP, Tsui DK, Li MK. The evolving influence of laparoscopy and laparoscopic ultrasonography on patients with hepatocellular carcinoma. Am J Surg 2008; 196: 736-740 [PMID: 18558389 DOI: 10.1016/j.amjsurg.2007.08.073]
54. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008; 47: 82-89 [PMID: 18008357 DOI: 10.1002/hep.21933]